Disease report

Tree Display

AceDB Schema

XML Display

Feedback

Disease Report for: Neuro-ocular DAGLA-related syndrome


Alternative name(s)|NODRS
Gene_locus|human-DAGLA
Mutation|7 mutations (e.g. : E814X_human-DAGLA, E829RfsX6_human-DAGLA, E829X_human-DAGLA... more)
OMIM: |614015

Comment
Seven unique DAGLA variants identified in nine children from eight families. All variants lead to premature protein truncation proximally in the final exon and disrupt multiple predicted phosphorylation sites and a protein-protein interaction domain with HOMER scaffolding proteins. Mutations where outside the alpha/beta hydrolase domain and had no effect on DAGLA enzymatic activity. The defect could be du to mis-localized DAGLA. Patients showed a neuro-ocular phenotype characterized by developmental delay, ataxia, and complex oculomotor abnormality with paroxysms of nystagmus or eye deviation accompanied by compensatory head posture and worsened incoordination most frequently after waking.

References
    Title: Endocannabinoid dysfunction in neurological disease: neuro-ocular DAGLA-related syndrome (NODRS)
    Bainbridge MN, Mazumder A, Ogasawara D, Abou Jamra R, Bernard G, Bertini E, Burglen L, Cope H, Crawford A and Friedman J <24 more author(s)>
    Ref: Brain, :, 2022 : PubMed

            


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer